INS1009-321 (PALM IPF)

Listing Category
Description


A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallelgroup Study of Efficacy and Safety of Treprostinil Palmitil Inhalation Powder inParticipants with Idiopathic Pulmonary Fibrosis (IPF) – PALM-IPF

Study Status
Upcoming Trial
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Scroll to Top